We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Watson and Andrx Extend Merger Deadline for FTC Review
Watson and Andrx Extend Merger Deadline for FTC Review
July 10, 2006
Watson Pharmaceuticals and Andrx have extended their merger deadline an additional two months to address the FTC’s review of the transaction, the companies said.